If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern 2 Vct Regulatory News (NTV)

Share Price Information for Northern 2 Vct (NTV)

Share Price is delayed by 15 minutes
Get Live Data
52.00    0.00 (0.00%)
Bid:
50.50
Ask:
53.50
Spread: 3.00 (5.941%)
Market Cap: £140.08m
NTV Live PriceLast checked at - London Stock Exchange

Intraday Northern 2 Vct Share Chart

Net Asset Value

10 Feb 2023 11:00

Net Asset Value

10 FEBRUARY 2023

NORTHERN 2 VCT PLC

UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2022

Northern 2 VCT PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1999 and managed by Mercia Fund Management Limited. The Company’s objective is to provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

The unaudited net asset value per ordinary share as at 31 December 2022 was 58.9 pence (30 September 2022 (unaudited) 60.2 pence).

The net asset value is stated before deducting the interim dividend of 2.0 pence per share in respect of the year ending 31 March 2023, which was paid to eligible shareholders on 13 January 2023.

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 31 December 2022 and unquoted investments are carried at fair value as at 31 December 2022 as determined by the directors.

New Investments:During the three months ended 31 December 2022 three new venture capital investments were completed.

Name of company Business activity Amount invested£000
Turbine Simulated Cell Technologies LtdSimulating cell reaction to the treatment of complex disease1,503
Axis Spine Technologies LtdDevelopment of next generation spinal implants1,002
Send Technology LtdUnderwriting workbench solutions for insurers, reinsurers, and managing general agents1,023
   

In addition to the new investments above, £2,199,000 was invested in nine existing portfolio companies during the quarter.

There were no venture capital exits during the quarter.

The number of ordinary shares in issue at 31 December 2022 was 186,083,476. During the three months ended 31 December 2022 no shares were allotted and 1,677,374 shares were purchased for cancellation at an average price of 56.9 pence per share.

Enquiries:

Sarah Williams / James Sly, Mercia Fund Management Ltd – 0330 223 1430

Website: www.mercia.co.uk/vcts

The contents of the Mercia Asset Management PLC website and the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website) are not incorporated into, nor form part of, this announcement.

Date   Source Headline
30th Sep 20254:30 pmGNWTotal voting rights
29th Sep 20252:00 pmGNWTransaction in Own Shares
24th Sep 20258:00 amGNWOffer for subscription
17th Sep 20253:00 pmGNWPublication of Prospectus
5th Sep 20258:00 amGNWIssue of Equity and Total Voting Rights
1st Sep 20257:00 amGNWTotal voting rights
27th Aug 20251:00 pmGNWTransaction in Own Shares
8th Aug 20257:00 amGNWNet Asset Value(s)
6th Aug 20254:00 pmGNWResult of AGM
31st Jul 202511:00 amGNWTotal voting rights
25th Jul 20257:00 amGNWAnnual Financial Report and Notice of AGM
3rd Jul 20257:00 amGNWTransaction in Own Shares
30th Jun 202511:00 amGNWTotal voting rights
17th Jun 20254:27 pmGNWAnnual Report and Financial Statements for the year ended 31 March 2025
17th Jun 20254:27 pmGNWDividend Declaration
17th Jun 20254:27 pmGNWStatement regarding intention to fundraise
30th May 20252:00 pmGNWDirectorate change
30th May 20257:00 amGNWTotal voting rights
30th Apr 202511:00 amGNWTotal voting rights
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202510:00 amGNWIssue of Equity and Total Voting Rights
31st Mar 202511:00 amGNWTotal voting rights
24th Mar 20254:30 pmGNWTransaction in Own Shares
18th Mar 20254:02 pmGNWOffer for subscription update
28th Feb 202511:00 amGNWTotal voting rights
6th Feb 20258:00 amGNWNet Asset Value
31st Jan 202511:00 amGNWTotal voting rights
22nd Jan 20258:01 amGNWDirector/PDMR Dealings
22nd Jan 20258:00 amGNWIssue of Equity and Total Voting Rights
17th Jan 20254:15 pmGNWTransaction in Own Shares
14th Jan 20258:00 amGNWOffer for subscription
9th Jan 20252:00 pmGNWPublication of Prospectus
31st Dec 202411:00 amGNWTotal voting rights
4th Dec 20248:00 amGNWTransaction in Own Shares
29th Nov 202411:00 amGNWTotal voting rights
21st Nov 20243:00 pmGNWHalf-yearly report
21st Nov 20242:01 pmGNWDividend Declaration
21st Nov 20242:00 pmGNWUnaudited Half-Yearly Financial Report for the Six Months Ended 30 September 2024
31st Oct 202411:00 amGNWTotal voting rights
16th Oct 20244:25 pmGNWDirector Declaration
4th Oct 20243:02 pmGNWDirector Declaration
30th Sep 202411:00 amGNWTotal voting rights
26th Sep 20248:00 amGNWTransaction in Own Shares
23rd Sep 202410:00 amGNWStatement regarding intention to fundraise
30th Aug 202411:00 amGNWTotal voting rights
23rd Aug 20248:30 amGNWDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.